Literature DB >> 23712247

Therapy: raising BMD-two drugs are better than one.

Linda Koch.   

Abstract

Year:  2013        PMID： 23712247     DOI： 10.1038/nrendo.2013.112

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

Authors:  Joy N Tsai; Alexander V Uihlein; Hang Lee; Ruchit Kumbhani; Erica Siwila-Sackman; Elizabeth A McKay; Sherri-Ann M Burnett-Bowie; Robert M Neer; Benjamin Z Leder
Journal:  Lancet       Date:  2013-05-15       Impact factor: 79.321
  1 in total
  1 in total

1.  Dual roles of QOA-8a in antiosteoporosis: a combination of bone anabolic and anti-resorptive effects.

Authors:  Jing Wu; Qi Shen; Wei Cui; Yu Zhao; Yue Huai; Yu-Chao Zhang; Bei-Hua Bao; Chen-Xi Liu; Qing Jiang; Jian-Xin Li
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.